Questionable universal validity of PAX3/FOXO1 fusion gene status as molecular marker for improvement of risk stratification in rhabdomyosarcoma therapy

J Clin Oncol. 2012 Nov 10;30(32):4039-40; author reply 4040-1. doi: 10.1200/JCO.2012.43.5628. Epub 2012 Oct 1.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Female
  • Forkhead Transcription Factors / genetics*
  • Gene Fusion / genetics*
  • Humans
  • Male
  • Paired Box Transcription Factors / genetics*
  • Rhabdomyosarcoma / genetics*
  • Rhabdomyosarcoma / mortality*

Substances

  • Forkhead Transcription Factors
  • Paired Box Transcription Factors